GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Real Brands Inc (OTCPK:RLBD) » Definitions » EBITDA

Real Brands (Real Brands) EBITDA : $-0.59 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Real Brands EBITDA?

Real Brands's EBITDA for the three months ended in Mar. 2024 was $-0.11 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.59 Mil.

During the past 3 years, the average EBITDA Growth Rate was 42.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 10 years, the highest 3-Year average EBITDA Growth Rate of Real Brands was 42.00% per year. The lowest was -142.20% per year. And the median was -10.50% per year.

Real Brands's EBITDA per Share for the three months ended in Mar. 2024 was $0.00. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 10 years, the highest 3-Year average EBITDA per Share Growth Rate of Real Brands was 90.70% per year. The lowest was 80.00% per year. And the median was 85.35% per year.


Real Brands EBITDA Historical Data

The historical data trend for Real Brands's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Real Brands EBITDA Chart

Real Brands Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec20 Dec21 Dec22 Dec23
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.59 -6.12 -2.60 -0.79 -1.20

Real Brands Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.72 -0.16 -0.19 -0.13 -0.11

Competitive Comparison of Real Brands's EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Real Brands's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Real Brands's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Real Brands's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Real Brands's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Real Brands's EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Real Brands's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2023, Real Brands's EBITDA was $-1.20 Mil.

Real Brands's EBITDA for the quarter that ended in Mar. 2024 is calculated as

Real Brands's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2024, Real Brands's EBITDA was $-0.11 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Real Brands  (OTCPK:RLBD) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Real Brands EBITDA Related Terms

Thank you for viewing the detailed overview of Real Brands's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Real Brands (Real Brands) Business Description

Traded in Other Exchanges
N/A
Address
12 Humbert Street, North Providence, RI, USA, 02991
Real Brands Inc is a brand-building company in the legal hemp and cannabis industry. Its brand includes CBD Pharmacy, Omega Hemp, Hempaid, and Humboldt among others. The company sells its hemp-based products to the wholesale and retail markets.
Executives
James Wells Dobbins director 5201 INTERCHANGE WAY, LOUISVILLE KY 40229
Thomas Kidrin officer: President and CEO 11 ROYAL ROAD, BROOKLINE MA 02445
Christopher John Ryan officer: CFO 11 ROYAL RD, BROOKLINE MA 02445
Leonard Toboroff director 39 N MOORE ST, STE 6B, NEW YORK NY 10013
Peter N Christos director
Turning Point Brands, Inc. 10 percent owner 5201 INTERCHANGE WAY, LOUISVILLE KY 40229
Brett S. Spitalny officer: Chief Operating Officer 2 SOUTH UNIVERSITY DRIVE, SUITE 220, PLANTATION FL 33324
Jerry Pearring director, officer: President & CEO 2 SOUTH UNIVERSITY DRIVE, SUITE 220, PLANTATION FL 33324
Ross E Silvey director 7633 EAST 63RD PLACE, #220, TULSA OK 74133
Terry J Turner director 7633 EAST 63RD PLACE, #220, TULSA OK 74133
Bernie Gurr officer: Chief Financial Officer 32751 MATTHEW DRIVE, DANA POINT CA 92629
Bruce Macgregor officer: Chief Executive Officer, Pres. 5092 RHOADS AVENUE UNIT A, SANTA BARBARA CA 93111
Ken Wiedrich director 43180 BUSINESS PARK DRIVE SUITE 202, TEMECULA CA 92590

Real Brands (Real Brands) Headlines

From GuruFocus

RLBD's Kidrin on Revs, M&A, and TPB

By ACCESSWIRE ACCESSWIRE 03-14-2022

Real Brands Inc. Uplists to OTCQB

By GuruFocusNews GuruFocusNews 03-02-2022